• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预防性植入式心脏复律除颤器在心脏正常患者中的应用。

Use of the prophylactic implantable cardioverter defibrillator for patients with normal hearts.

作者信息

Brugada P, Brugada R, Brugada J, Geelen P

机构信息

Cardiovascular Research and Teaching Institute, Aalst, Belgium.

出版信息

Am J Cardiol. 1999 Mar 11;83(5B):98D-100D. doi: 10.1016/s0002-9149(98)01009-1.

DOI:10.1016/s0002-9149(98)01009-1
PMID:10089849
Abstract

About 10-20% of patients dying suddenly and unexpectedly do not have structural heart disease. The major causes of sudden death in this population are acute ischemia, the syndrome of right bundle branch block, and ST-elevation from V1 to V3, the long QT-syndrome, and the Wolff-Parkinson-While syndrome. In some patients, none of these syndromes can be recognized and ventricular fibrillation is classified as idiopathic. There are good preventive and therapeutic methods against acute ischemia and there are also curative treatments for the Wolff-Parkinson-White syndrome. Patients with idiopathic ventricular fibrillation cannot be recognized beforehand. However, there are electrocardiographic and genetic markers for the Brugada syndrome and the long QT syndrome. It is, therefore, justified to discuss the possible role of the prophylactic defibrillator to prevent sudden death in these 2 syndromes for which no effective treatment exists. Patients with Brugada syndrome have a high incidence of sudden death, and prophylactic defibrillators are indicated in patients with inducible arrhythmias at electrophysiologic study, irrespective of symptoms. On the contrary, the incidence of sudden death in the long QT syndrome is very low, making prophylactic defibrillator implantation not cost-effective.

摘要

约10% - 20%突然意外死亡的患者并无结构性心脏病。这部分人群猝死的主要原因包括急性缺血、右束支传导阻滞综合征、V1至V3导联ST段抬高、长QT综合征以及预激综合征。在一些患者中,无法识别出这些综合征,室颤被归类为特发性。针对急性缺血有很好的预防和治疗方法,对于预激综合征也有治愈性治疗。特发性室颤患者无法预先识别。然而,Brugada综合征和长QT综合征存在心电图和基因标志物。因此,对于这两种尚无有效治疗方法的综合征,讨论预防性除颤器预防猝死的可能作用是合理的。Brugada综合征患者猝死发生率高,对于电生理检查可诱发心律失常的患者,无论有无症状,均建议植入预防性除颤器。相反,长QT综合征的猝死发生率很低,植入预防性除颤器不具有成本效益。

相似文献

1
Use of the prophylactic implantable cardioverter defibrillator for patients with normal hearts.预防性植入式心脏复律除颤器在心脏正常患者中的应用。
Am J Cardiol. 1999 Mar 11;83(5B):98D-100D. doi: 10.1016/s0002-9149(98)01009-1.
2
Implantable cardioverter-defibrillators in lamin A/C mutation carriers with cardiac conduction disorders.植入型心律转复除颤器在伴心脏传导障碍的核纤层蛋白 A/C 突变携带者中的应用。
Heart Rhythm. 2013 Oct;10(10):1492-8. doi: 10.1016/j.hrthm.2013.06.020. Epub 2013 Jun 26.
3
Brugada and long QT-3 syndromes: two phenotypes of the sodium channel disease.布加迪综合征和长QT-3综合征:钠通道疾病的两种表型。
Ann Noninvasive Electrocardiol. 2004 Jul;9(3):280-9. doi: 10.1111/j.1542-474X.2004.93533.x.
4
What is the Brugada syndrome?什么是 Brugada 综合征?
Cardiol Rev. 1999 Jul-Aug;7(4):191-5. doi: 10.1097/00045415-199907000-00010.
5
[Right bundle branch block and ST-segment elevation in right precordial leads: a marker for sudden cardiac death].[右束支传导阻滞及右胸导联ST段抬高:心脏性猝死的一个标志物]
Orv Hetil. 2000 Mar 19;141(12):615-7.
6
Right bundle-branch block and ST-segment elevation in leads V1 through V3: a marker for sudden death in patients without demonstrable structural heart disease.V1至V3导联出现右束支传导阻滞及ST段抬高:无明显结构性心脏病患者猝死的一个标志物。
Circulation. 1998 Feb 10;97(5):457-60. doi: 10.1161/01.cir.97.5.457.
7
Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy.植入式心脏复律除颤器对肥厚型心肌病患者预防猝死的疗效。
N Engl J Med. 2000 Feb 10;342(6):365-73. doi: 10.1056/NEJM200002103420601.
8
Electrical Substrate Elimination in 135 Consecutive Patients With Brugada Syndrome.135例Brugada综合征患者的电基质消除
Circ Arrhythm Electrophysiol. 2017 May;10(5):e005053. doi: 10.1161/CIRCEP.117.005053.
9
Sudden cardiac death without structural heart disease: update on the long QT and Brugada syndromes.无结构性心脏病的心脏性猝死:长QT综合征和Brugada综合征的最新进展
Curr Cardiol Rep. 2005 Sep;7(5):349-56. doi: 10.1007/s11886-005-0088-1.
10
Mechanisms and clinical management of inherited channelopathies: long QT syndrome, Brugada syndrome, catecholaminergic polymorphic ventricular tachycardia, and short QT syndrome.遗传性通道病的机制和临床处理:长 QT 综合征、Brugada 综合征、儿茶酚胺多形性室性心动过速和短 QT 综合征。
Heart Rhythm. 2009 Aug;6(8 Suppl):S51-5. doi: 10.1016/j.hrthm.2009.02.009. Epub 2009 Feb 12.

引用本文的文献

1
Long-term follow-up of patients with Brugada syndrome: Foremost risk factors associated with overall arrhythmic events.Brugada综合征患者的长期随访:与总体心律失常事件相关的首要危险因素。
Medicine (Baltimore). 2024 May 3;103(18):e37990. doi: 10.1097/MD.0000000000037990.
2
HiPSC-derived cardiomyocyte to model Brugada syndrome: both asymptomatic and symptomatic mutation carriers reveal increased arrhythmogenicity.人诱导多能干细胞衍生心肌细胞模型 Brugada 综合征:无症状和有症状突变携带者均显示出增加的心律失常倾向。
BMC Cardiovasc Disord. 2023 Apr 25;23(1):208. doi: 10.1186/s12872-023-03234-7.
3
Lack of association between mitochondrial DNA haplogroups J and T and clinical manifestation in Russian patients with Brugada syndrome.
俄罗斯布加综合征患者线粒体DNA单倍群J和T与临床表现之间缺乏关联。
Biomed Rep. 2020 Sep;13(3):16. doi: 10.3892/br.2020.1324. Epub 2020 Jul 2.
4
QT Prolongation and Malignant Arrhythmia: How Serious a Problem?QT间期延长与恶性心律失常:问题有多严重?
Eur Cardiol. 2017 Dec;12(2):112-120. doi: 10.15420/ecr.2017:16:1.
5
Sodium channel current loss of function in induced pluripotent stem cell-derived cardiomyocytes from a Brugada syndrome patient.致心律失常性右室心肌病患者诱导多能干细胞衍生心肌细胞钠离子通道电流功能丧失。
J Mol Cell Cardiol. 2018 Jan;114:10-19. doi: 10.1016/j.yjmcc.2017.10.002. Epub 2017 Oct 9.
6
J-Wave syndromes expert consensus conference report: Emerging concepts and gaps in knowledge.J波综合征专家共识会议报告:新出现的概念与知识空白
Europace. 2017 Apr 1;19(4):665-694. doi: 10.1093/europace/euw235.
7
J-Wave syndromes expert consensus conference report: Emerging concepts and gaps in knowledge.J波综合征专家共识会议报告:新出现的概念与知识空白
J Arrhythm. 2016 Oct;32(5):315-339. doi: 10.1016/j.joa.2016.07.002. Epub 2016 Aug 21.
8
Novel Therapeutic Strategies for the Management of Ventricular Arrhythmias Associated with the Brugada Syndrome.治疗与Brugada综合征相关室性心律失常的新型策略
Expert Opin Orphan Drugs. 2015;3(6):633-651. doi: 10.1517/21678707.2015.1037280. Epub 2015 May 13.
9
Risk factors for cardiac events in patients with Brugada syndrome: A PRISMA-compliant meta-analysis and systematic review.Brugada综合征患者心脏事件的危险因素:一项遵循PRISMA标准的荟萃分析和系统评价
Medicine (Baltimore). 2016 Jul;95(30):e4214. doi: 10.1097/MD.0000000000004214.
10
J-Wave syndromes expert consensus conference report: Emerging concepts and gaps in knowledge.J波综合征专家共识会议报告:新出现的概念与知识空白
Heart Rhythm. 2016 Oct;13(10):e295-324. doi: 10.1016/j.hrthm.2016.05.024. Epub 2016 Jul 13.